Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.

Gibson CM, Steg PG, Bahit MC, Al-Lamee R, Mehta SR, Mehran R, Weitz JI, Goto S, Nicolau JC, Lopes RD, Ge J, Tasic N, Angiolillo DJ, Baron SJ, Kirtane AJ, Xavier D, Yasuda S, Lewis BS, Park DW, Cornel JH, Johnson TW, Trebacz J, Duerschmied D, Bode C, Merkely B, Dorobantu M, Vinereanu D, Motovska Z, Bueno H, Lopez-Sendon JL, Ducrocq G, Ambrosio G, Burgess L, Bohm A, Chiang CE, Morais J, Fong A, Guray U, Leiva-Pons JL, Vranckx P, White HD, Kedev S, Valgimigli M, Cerovec D, Tousoulis D, Figtree G, Ho TD, Sy RG, Bøttcher M, Huber K, Slapikas R, Erglis A, Tan JWC, Pincetti C, Pieper KS, Mahaffey KW, Lam CSP, Johnston SC, Hankey GJ, Zheng L, Aronson R, Li D, Notani R, Vieira Pires P, Povsic TJ, Lindsay AC, Plotnikov A, Deng H, Barnathan ES, Harrington RA, LIBREXIA ACS Committees and Investigators.

Open source

DOI: 10.1056/nejmoa2608717
Published: 2026-08-29
Container: N Engl J Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2608717,
  title = {Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.},
  author = {Gibson CM and  Steg PG and  Bahit MC and  Al-Lamee R and  Mehta SR and  Mehran R and  Weitz JI and  Goto S and  Nicolau JC and  Lopes RD and  Ge J and  Tasic N and  Angiolillo DJ and  Baron SJ and  Kirtane AJ and  Xavier D and  Yasuda S and  Lewis BS and  Park DW and  Cornel JH and  Johnson TW and  Trebacz J and  Duerschmied D and  Bode C and  Merkely B and  Dorobantu M and  Vinereanu D and  Motovska Z and  Bueno H and  Lopez-Sendon JL and  Ducrocq G and  Ambrosio G and  Burgess L and  Bohm A and  Chiang CE and  Morais J and  Fong A and  Guray U and  Leiva-Pons JL and  Vranckx P and  White HD and  Kedev S and  Valgimigli M and  Cerovec D and  Tousoulis D and  Figtree G and  Ho TD and  Sy RG and  Bøttcher M and  Huber K and  Slapikas R and  Erglis A and  Tan JWC and  Pincetti C and  Pieper KS and  Mahaffey KW and  Lam CSP and  Johnston SC and  Hankey GJ and  Zheng L and  Aronson R and  Li D and  Notani R and  Vieira Pires P and  Povsic TJ and  Lindsay AC and  Plotnikov A and  Deng H and  Barnathan ES and  Harrington RA and  LIBREXIA ACS Committees and Investigators.},
  year = {2026},
  journal = {N Engl J Med},
  doi = {10.1056/nejmoa2608717},
  url = {https://doi.org/10.1056/nejmoa2608717}
}

RIS

TY  - JOUR
TI  - Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
AU  - Gibson CM
AU  -  Steg PG
AU  -  Bahit MC
AU  -  Al-Lamee R
AU  -  Mehta SR
AU  -  Mehran R
AU  -  Weitz JI
AU  -  Goto S
AU  -  Nicolau JC
AU  -  Lopes RD
AU  -  Ge J
AU  -  Tasic N
AU  -  Angiolillo DJ
AU  -  Baron SJ
AU  -  Kirtane AJ
AU  -  Xavier D
AU  -  Yasuda S
AU  -  Lewis BS
AU  -  Park DW
AU  -  Cornel JH
AU  -  Johnson TW
AU  -  Trebacz J
AU  -  Duerschmied D
AU  -  Bode C
AU  -  Merkely B
AU  -  Dorobantu M
AU  -  Vinereanu D
AU  -  Motovska Z
AU  -  Bueno H
AU  -  Lopez-Sendon JL
AU  -  Ducrocq G
AU  -  Ambrosio G
AU  -  Burgess L
AU  -  Bohm A
AU  -  Chiang CE
AU  -  Morais J
AU  -  Fong A
AU  -  Guray U
AU  -  Leiva-Pons JL
AU  -  Vranckx P
AU  -  White HD
AU  -  Kedev S
AU  -  Valgimigli M
AU  -  Cerovec D
AU  -  Tousoulis D
AU  -  Figtree G
AU  -  Ho TD
AU  -  Sy RG
AU  -  Bøttcher M
AU  -  Huber K
AU  -  Slapikas R
AU  -  Erglis A
AU  -  Tan JWC
AU  -  Pincetti C
AU  -  Pieper KS
AU  -  Mahaffey KW
AU  -  Lam CSP
AU  -  Johnston SC
AU  -  Hankey GJ
AU  -  Zheng L
AU  -  Aronson R
AU  -  Li D
AU  -  Notani R
AU  -  Vieira Pires P
AU  -  Povsic TJ
AU  -  Lindsay AC
AU  -  Plotnikov A
AU  -  Deng H
AU  -  Barnathan ES
AU  -  Harrington RA
AU  -  LIBREXIA ACS Committees and Investigators.
PY  - 2026
JO  - N Engl J Med
DO  - 10.1056/nejmoa2608717
UR  - https://doi.org/10.1056/nejmoa2608717
ER  -

APA

CM, G., PG, S., MC, B., R, A., SR, M., R, M., JI, W., S, G., JC, N., RD, L., J, G., N, T., DJ, A., SJ, B., AJ, K., D, X., S, Y., BS, L., DW, P., JH, C., TW, J., J, T., D, D., C, B., B, M., M, D., D, V., Z, M., H, B., JL, L., G, D., G, A., L, B., A, B., CE, C., J, M., A, F., U, G., JL, L., P, V., HD, W., S, K., M, V., D, C., D, T., G, F., TD, H., RG, S., M, B., K, H., R, S., A, E., JWC, T., C, P., KS, P., KW, M., CSP, L., SC, J., GJ, H., L, Z., R, A., D, L., R, N., P, V. P., TJ, P., AC, L., A, P., H, D., ES, B., RA, H., & Investigators., L. A. C. A. (2026). Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.. N Engl J Med. https://doi.org/10.1056/nejmoa2608717

Source records

europe-pmc · retrieved 2026-09-25T19:21:48.641Z